Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CE-STAND: Cervical Epidural STimulation After Neurologic Damage

NCT: NCT06410001 · RECRUITING

NCT IDNCT06410001
StatusRECRUITING
Start Date2026-03-15
Completion2030-07-30

Brief Summary

CE-STAND aims to address three areas under-represented in research: chronic, cervical, and autonomic dysfunction. It is both significant and highly impactful, as treating autonomic dysfunction could substantially improve function and quality of life (QoL) in chronic cervical SCI patients.

Frequently Asked Questions

What is CE-STAND: Cervical Epidural STimulation After Neurologic Damage?

CE-STAND: Cervical Epidural STimulation After Neurologic Damage is a clinical trial registered under NCT06410001. Current status: RECRUITING.

What is the status of NCT06410001?

The current status of NCT06410001 (CE-STAND: Cervical Epidural STimulation After Neurologic Damage) is: RECRUITING.

When did CE-STAND: Cervical Epidural STimulation After Neurologic Damage start?

CE-STAND: Cervical Epidural STimulation After Neurologic Damage started on 2026-03-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑